T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
AbbVie
ABBV
$440B
| $1.77B | 0.25% |
13,164,714
-4,411,166
| -25% | -$647M |
|
77
HCA Healthcare
HCA
$89.8B
| $1.74B | 0.24% |
5,746,410
-2,227,614
| -28% | -$619M |
|
78
Hartford Financial Services
HIG
$37.7B
| $1.67B | 0.23% |
23,134,297
-2,977,186
| -11% | -$209M |
|
79
Constellation Brands
STZ
$22.9B
| $1.64B | 0.23% |
6,652,789
-1,237,913
| -16% | -$290M |
|
80
Walt Disney
DIS
$178B
| $1.63B | 0.23% |
18,301,007
-7,715,609
| -30% | -$731M |
|
81
Amphenol
APH
$210B
| $1.63B | 0.23% |
38,282,706
+8,896,290
| +30% | +$346M |
|
82
Regeneron Pharmaceuticals
REGN
$82.2B
| $1.62B | 0.23% |
2,252,263
+74,031
| +3% | +$57.1M |
|
83
American International
AIG
$39.8B
| $1.59B | 0.22% |
27,636,712
+750,515
| +3% | +$40.3M |
|
84
CSX Corp
CSX
$92.8B
| $1.58B | 0.22% |
46,448,103
-5,117,759
| -10% | -$162M |
|
85
Las Vegas Sands
LVS
$29.6B
| $1.58B | 0.22% |
27,164,433
-5,776,952
| -18% | -$342M |
|
86
Stanley Black & Decker
SWK
$15.5B
| $1.56B | 0.22% |
16,673,230
+945,536
| +6% | +$78.3M |
|
87
Progressive
PGR
$121B
| $1.56B | 0.22% |
11,796,663
+5,557
| +0% | +$745K |
|
|
MRSH
88
Marsh
MRSH
$90.1B
| $1.55B | 0.22% |
8,245,479
-1,387,284
| -14% | -$246M |
|
|
89
EQT Corp
EQT
$33.8B
| $1.54B | 0.21% |
37,406,939
+36,915,220
| +7,507% | +$1.31B |
|
90
Weyerhaeuser
WY
$17.8B
| $1.53B | 0.21% |
45,586,908
-395,116
| -0.9% | -$11.9M |
|
91
Zoetis
ZTS
$30.4B
| $1.52B | 0.21% |
8,821,352
-1,454,141
| -14% | -$251M |
|
92
argenx
ARGX
$54.8B
| $1.52B | 0.21% |
3,897,419
+73,436
| +2% | +$28.9M |
|
93
TE Connectivity
TEL
$62B
| $1.5B | 0.21% |
10,687,905
+2,187,440
| +26% | +$277M |
|
94
Cadence Design Systems
CDNS
$89B
| $1.48B | 0.21% |
6,305,038
+861,056
| +16% | +$187M |
|
95
BILL Holdings
BILL
$4.85B
| $1.47B | 0.2% |
12,538,125
-209,991
| -2% | -$19.9M |
|
96
Hubbell
HUBB
$27.1B
| $1.46B | 0.2% |
4,407,519
-620,491
| -12% | -$172M |
|
97
Medtronic
MDT
$116B
| $1.46B | 0.2% |
16,565,842
+6,302,067
| +61% | +$543M |
|
98
US Bancorp
USB
$101B
| $1.45B | 0.2% |
43,779,668
-3,057,927
| -7% | -$98.8M |
|
|
DAY
99
DELISTED
Dayforce
DAY
| $1.44B | 0.2% |
21,448,529
+776,682
| +4% | +$50M |
|
100
Goldman Sachs
GS
$302B
| $1.41B | 0.2% |
4,386,925
+640,696
| +17% | +$211M |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.